02.10.2018 • NewsElaine BurridgeWestlake

Westlake Bids for French Compounder Nakan

Westlake Bids for French Compounder Nakan
Westlake Bids for French Compounder Nakan

US petrochemicals and plastics producer Westlake has made an exclusive binding offer of about $265 million in cash to buy Nakan, a French compounding business that is owned by private equity group OpenGate Capital.

The offer, which is subject to adjustment, was made so that Nakan can start consulting with French works councils prior to entering into a negotiated, mutually binding purchase agreement.

“The combination of Nakan with Westlake’s existing compounding business will present an excellent strategic fit. It will allow us to expand our compounding business globally and add important specialty products and technology to our existing portfolio,” said Albert Chao, Westlake’s president and CEO.

Headquartered in Reims, Nakan has eight production plants in France, Germany, Italy, Spain, Mexico, China, Japan and Vietnam, along with a research facility in France and an application laboratory in the US. The company had sales of around $300 million in the most recent twelve-month period.

The transaction is expected to close by early 2019, subject to regulatory approvals, completion of required employee consultation procedures and other customary closing conditions.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.